Net Asset Value • Dec 10, 2025
Net Asset Value
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 0505L
Chemring Group PLC
10 December 2025
10 December 2025
Chemring Group PLC
Grant of deferred share award
Chemring Group PLC ("Chemring" or the "Company") announces that on 9 December 2025 it granted an award of 41,717 deferred 1p ordinary shares in the capital of the Company to James Mortensen, a director of the Company, in satisfaction of 40% of Mr Mortensen's annual bonus payment for the year ended 31 October 2025. The deferred share award will vest in three years' time.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
James Mortensen
2
Reason for the notification
a)
Position/status
Director/PDMR
b)
Initial notification /Amendment
Initial
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Chemring Group PLC
b)
LEI
213800U9A54VQJ5P2J41
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Deferred award over 1p ordinary shares
GB00B45C9X44
b)
Nature of the transaction
Deferred award of shares in partial satisfaction of an annual bonus payment
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| Nil | 41,717 |
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
9 December 2025
f)
Place of the transaction
Outside a trading venue
For further information:
| Chemring Group PLC | ||
| Sarah Ellard | Group Legal Director & Company Secretary | +44 (0)7710 553757 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFVFFTLILIE
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.